Safety and Pharmacokinetics of an Intramuscular Monoclonal Antibody (SB 209763) Against Respiratory Syncytial Virus (RSV) in Infants and Young Children at Risk for Severe RSV Disease
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.43.5.1183
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 1999
Authors
Publisher
American Society for Microbiology